Patent · US Active

Immunogenic composition

US9290565B2 · kind B2 · utility

4Cited by

0References

3Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventor

Cindy Castado · Rixensart, BE

Key dates

Filing date	May 25, 2012
Grant date	Mar 22, 2016
Priority date	—
Expiry date	May 25, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to fusion proteins comprising fragments of toxin A and toxin B from Clostridium difficile, such as wherein the first fragment and the second fragment are adjacent to one another and wherein the first repeat portion and the second repeat portion have sequence similarity to one another.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.